STAT

SEPTEMBER 6, 2023

Congress previously drew this dubious distinction in 2010, when the biosimilar pathway it set up via the Biologics Price Competition and Innovation Act (BPCIA) conferred 12 years of data exclusivity on originator biologics, seven more than is given to originator small molecules under the Hatch-Waxman Act.

Biosimilars 337

Biosimilars Drug Pricing 337

European Pharmaceutical Review

JULY 17, 2023

billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. million publications describing basic or applied research related to 386 of 387 drugs approved 2010-2019 with $8.1 This was ~10 percent of reported industry spending. billion (3.3

Documentation 98

Documentation 98

Drug Patent Watch

JULY 28, 2023

A review article in the Journal of Pharmaceutical Sciences analyzes the trends in drug repurposing through the 505(b)(2) pathway, as approved by the USFDA from 2010 to 2020.

97

97

STAT

MARCH 26, 2024

From 1919 to 1952, more than 20,000 nonconsensual sterilizations took place in that state; the law was not repealed until 1979 in state hospitals and, frighteningly, was still in effect in state prisons until 2010. Read the rest…

Hospitals 324

Hospitals 324

STAT

DECEMBER 20, 2023

  Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019, when the fraud came to light. The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company that sold devices containing dummy pieces of plastic, with defrauding investors out of $41 million. 

341

341

STAT

SEPTEMBER 29, 2024

A Steward spokesperson did not say on Saturday if de la Torre will remain a major shareholder in the company he helped found in Boston in 2010. Continue to STAT+ to read the full story…

Hospitals 291

Hospitals 291

STAT

MARCH 7, 2024

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts of health care fraud. The maximum jail sentence for each count is 20 years.

324

324

STAT

MAY 8, 2023

That’s according to Gail Wilensky, who has been on the board of Geisinger since 2010. A long-running flurry of hospital and medical group acquisitions in Pennsylvania — especially among the giants UPMC and Highmark Health — forced Geisinger to make a bigger move of its own and to sell to Kaiser Permanente.

Hospitals 246

Hospitals 246

STAT

MARCH 26, 2024

Foundation, established in 2010 and later acquired by the Swiss drug giant Roche, had workers scattered among four locations, including its former headquarters in Cambridge.

Drug Development 278

Drug Development 278

STAT

JANUARY 10, 2023

The Food and Drug Administration approved 378 new drugs between 2010 and 2019, a big chunk of which were cancer medicines. The returns on biotech stocks were phenomenal.

Drug Development 255

Drug Development 255

STAT

FEBRUARY 14, 2024

WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

246

246

STAT

JULY 6, 2023

business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. At the time, David Ricks was running Lilly’s U.S.

255

255

STAT

AUGUST 8, 2023

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010 , according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

246

246

STAT

AUGUST 23, 2023

When President Obama signed the ACA into law on March 23, 2010, reproductive health took a giant step forward with its commonsense yet revolutionary approach. Barbara Mikulski — fought for coverage of women’s preventive services like mammograms, cervical cancer screenings, prenatal care, and, yes, contraception.

246

246

EMCrit Project

MAY 16, 2024

In the early 2010's, a series of retrospective correlational studies found that patients treated […] EMCrit Project by Josh Farkas. Combine this with the conservatism that often (rightfully) surrounds drug safety, and it creates a lot of volatility. Before going further, we should review some recent history regarding piptazo.

131

131

Express Pharma

MAY 5, 2025

Tokali concludes, The TCI market has seen an incredible surge in deal activity, with a 1,600 per cent increase in deal volume from 2010 to 2024. GlobalData projects 44 new TCI drug approvals by 2029, with 18 expected in 2027 alone.

64

64

Drug Patent Watch

JULY 27, 2023

Here’s a summary of a new article that used DrugPatentWatch data: NIH Funding for Patents That Contribute to Market Exclusivity of Drugs Approved 2010–2019 and the Public Interest Protections of… The post DrugPatentWatch reveals NIH funding for patents appeared first on DrugPatentWatch - Make Better Decisions.

97

97

Express Pharma

MARCH 27, 2024

Established in 2010, Heads has operational presence in 25 multiple strategically important locations across Europe, North America and Asia Pacific region. Veeda Clinical Research has acquired Heads, a privately held European CRO, which specialises in conducting clinical trials in oncology.

111

111

Express Pharma

JUNE 24, 2024

Sun Pharma has been the majority shareholder of Taro since 2010. As part of this merger, Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliates. As a result of the merger, Taro is now a private company and wholly owned by Sun Pharma.

95

95

The Guardian - Pharmaceutical Industry

AUGUST 24, 2024

The chancellor, Rachel Reeves, warns that hard choices on tax, spending and borrowing need to be made on 30 October when she delivers the first Labour budget since 2010, so poor is the economic legacy. The chancellor must step in Just how bad is the economy? Phooey, respond those still standing in the shredded Tory party.

106

106

pharmaphorum

MAY 6, 2021

McKenna has been with STEM since 2010, founding it in the US and Brazil before taking over the CEO role from co-founder Rob Wood in 2018. He will oversee the online performance marketing and digital benchmarking agency’s growth in the US joins Rob Wood and Barrie Brien on performance-io’s non-executive board.

119

119

ALiEM - Pharm Pearls

OCTOBER 7, 2024

2010 Dec;14(6):502-5. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29489275. Merino P, Gómez de Liaño P, Villalobo JM, Franco G, Gómez de Liaño R. Etiology and treatment of pediatric sixth nerve palsy. doi: 10.1016/j.jaapos.2010.09.009. 2010.09.009. PMID: 21168073.

161

161

Express Pharma

JANUARY 14, 2025

The nutraceutical market began to gain traction around 2005-2010, growing steadily since then. People are increasingly leaning towards prevention and preventive care rather than relying solely on therapeutic medications. However, the COVID-19 pandemic served as a significant turning point, increasing awareness about health and wellness.

Diabetes 105

Diabetes Compounding 105

Putting Patients First Blog

SEPTEMBER 7, 2023

However, the percentage of registrants using weekend (also called twice-weekly) dosing increased, with registrants born more recently (during or after 2010) being more likely to use a weekend dosing schedule than those who were born before 2010 (28% versus 9%).

Drug Pricing 111

Drug Pricing 111

ALiEM - Pharm Pearls

SEPTEMBER 15, 2023

Nat Rev Rheumatol 2010; 6:715. Repetitive motion occupations, tobacco use, alcohol use, and diabetes are key risk factors. References Shih B, Bayat A. Scientific understanding and clinical management of Dupuytren disease. Trojian TH, Chu SM. Dupuytren’s disease: diagnosis and treatment. Am Fam Physician 2007; 76:86.

Diabetes 152

Diabetes Clinic Management 152

RX Note

MARCH 31, 2025

External Links Ear drops for the removal of earwax, 2018 FDA Takes a Stand Against Ear Candling, 2010 Summary If any ear wax remains despite treatment to soften the wax for 3-5 days, referral for ear irrigation may be advisable.

Community Pharmacies 52

Community Pharmacies 52

Pharmaceutical Technology

JUNE 12, 2023

Currently, Jazz Pharmaceuticals’s nabiximols is the only cannabinoid approved for pain, receiving approval in Israel, in August 2010. In 2022, Pfizer acquired the drug, with the promise of accelerating clinical development via new, differentiated, and best-in-class approaches, enhancing optimism for further drug development.

Immunity 143

Immunity Immunization Drug Development 143

pharmaphorum

SEPTEMBER 24, 2020

The charges relate to a period from 2007 until the end of 2010, when the Department of Justice alleges California-based Gilead routinely obtained data from the foundation detailing how much the foundation had spent for patients on Letairis.

Drug Pricing 98

Drug Pricing 98

European Pharmaceutical Review

AUGUST 26, 2022

Moderna has filed patent infringement lawsuits alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty ® infringes patents Moderna filed between 2010 and 2016 covering its foundational messenger RNA (mRNA) technology.

Vaccines 98

Vaccines Immunity Immunization 98

Pharma Pathway

JANUARY 12, 2023

Ltd was incorporated in January 2010 and was founded by a group of experienced industry professionals. SunGlow Lifescience Pvt. Ltd-Openings for Production/ QC/ RA/ QMS/ ARD/ FRD/ Boiler Operator Dept. Job Description. SunGlow Lifescience Pvt. Our Corporate office is located in Chennai, Indian.

79

79

RX Note

APRIL 16, 2023

Compounding Sterile Preparations, 2018 Guide to the Development of Sterile Pharmaceutical Preparation Facilities, 2010 NOTE: Best refer PIC/S for the updated info. Manual for Sterile Preparations, 2021 NOTE: May refer PIC/S for more info.

Compounding 52

Compounding 52

Pharmaceutical Commerce

JANUARY 25, 2024

Tesamorelin (Egrifta) was initially approved by the FDA in November 2010 for the treatment of lipodystrophy in patients also diagnosed with HIV.

52

52

FADIC

AUGUST 11, 2023

Calculation of 2010 IF of a journal To calculate the 2010 Impact Factor of a journal, we would look at the citations received by the journal in 2010 and divide that number by the total number of articles published in the journal in 2008 and 2009. Where to find Journal Impact Factors? How is the Journal Impact Factor Calculated?

91

91

FDA Law Blog: Biosimilars

AUGUST 12, 2024

In February 2010, an oral formulation of BRAVECTO, a medication to treat and prevent fleas and tick infestation in dogs, was the subject of an INAD submitted to the Agency. With this decision, the testing phase for BRAVECTO began on February 19, 2010, giving Plaintiffs an additional year to be included in its testing phase calculations.

59

59

pharmaphorum

MARCH 19, 2021

She is founder and host of the podcast and television segment “Human Condition MD” She graduated from George Washington University School Of Medicine in 2010. She is routinely seen on CBS, FOX 5, NBC, ABC and MHz Networks. Based in London, Catherine has international experience and reported from across Europe, the U.S

Compounding 141

Compounding Pharmaceutical Companies Pharmaceutical Companies Communication 141

Pharma Pathway

JANUARY 31, 2023

Ltd was incorporated in January 2010 and was founded by a group of experienced industry professionals. Ltd-Walk-In Interviews for Production/ QC/ RA/ QMS/ ARD/ FRD/ Boiler Operator/ Maintenance/ Engineering/ Warehouse/ Regulatory Affairs/ QA On 5th Feb’ 2023 Job Description SunGlow Lifescience Pvt.

86

86

World Pharma News

FEBRUARY 25, 2025

Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for melanoma. Since then, many therapeutic - as opposed to preventive - cancer vaccines have been in development, but none approved.

Vaccines 49

Vaccines Immunity Immunization 49